1. Home
  2. RGEN vs AES Comparison

RGEN vs AES Comparison

Compare RGEN & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • AES
  • Stock Information
  • Founded
  • RGEN 1981
  • AES 1981
  • Country
  • RGEN United States
  • AES United States
  • Employees
  • RGEN N/A
  • AES N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • AES Electric Utilities: Central
  • Sector
  • RGEN Health Care
  • AES Utilities
  • Exchange
  • RGEN Nasdaq
  • AES Nasdaq
  • Market Cap
  • RGEN 6.5B
  • AES 7.1B
  • IPO Year
  • RGEN N/A
  • AES 1991
  • Fundamental
  • Price
  • RGEN $112.84
  • AES $12.89
  • Analyst Decision
  • RGEN Buy
  • AES Hold
  • Analyst Count
  • RGEN 10
  • AES 8
  • Target Price
  • RGEN $163.78
  • AES $13.29
  • AVG Volume (30 Days)
  • RGEN 671.7K
  • AES 8.8M
  • Earning Date
  • RGEN 11-11-2025
  • AES 10-30-2025
  • Dividend Yield
  • RGEN N/A
  • AES 5.40%
  • EPS Growth
  • RGEN N/A
  • AES 8.40
  • EPS
  • RGEN N/A
  • AES 1.28
  • Revenue
  • RGEN $673,956,000.00
  • AES $12,032,000,000.00
  • Revenue This Year
  • RGEN $16.74
  • AES $2.44
  • Revenue Next Year
  • RGEN $13.86
  • AES $4.21
  • P/E Ratio
  • RGEN N/A
  • AES $10.17
  • Revenue Growth
  • RGEN 8.73
  • AES N/A
  • 52 Week Low
  • RGEN $102.97
  • AES $9.46
  • 52 Week High
  • RGEN $182.52
  • AES $20.30
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 40.15
  • AES 46.96
  • Support Level
  • RGEN $112.73
  • AES $12.70
  • Resistance Level
  • RGEN $122.71
  • AES $13.20
  • Average True Range (ATR)
  • RGEN 4.16
  • AES 0.32
  • MACD
  • RGEN -0.90
  • AES -0.05
  • Stochastic Oscillator
  • RGEN 1.03
  • AES 41.29

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About AES The AES Corporation

AES is a global power company that operates in 15 countries. Its generation portfolio as of year-end 2023 totals over 35 gigawatts, including renewable energy (53%), gas (27%), coal (18%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.

Share on Social Networks: